William A. Haseltine
Chairman and Presidentjvyyvnz.email@example.com
William A. Haseltine, PhD, has an active career in both science and business. He was a professor at Harvard Medical School and Harvard School of Public Health from 1976 to 1993, where he was founder and the chair of two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology. He is well known for his pioneering work on cancer, HIV/AIDS, and genomics. He has authored more than two hundred manuscripts in peer reviewed journals and is the author of several books, including Affordable Excellence: The Singapore Healthcare Story, published in 2013. He is the founder of Human Genome Sciences, Inc., and served as the chairman and CEO of the company until 2004. He is also the founder of several other successful biotechnology companies. Companies he has founded account for seven drugs currently on the market. He is chairman of the Haseltine Foundation for Science and the Arts. He serves as an advisor and board member of several innovative healthcare companies.
He is chairman of the US-China Health Summit and a member of the advisory board of the IE University, Madrid, and the advisory council for the Koch Institute of MIT and the Life Sciences Foundation. He is a member of the advisory boards of the Council of Scientific and Industrial Research (India), the Ragon Institute, the FXB Center for Health and Human Rights at the Harvard School of Public Health and the Council of Scientific and Industrial Research (CSIR) of India. He is also a Lifetime Governor of the New York Academy of Sciences, a member of the board of AID for AIDS International, an honorary member of the Board of Trustees of the Brookings Institution, and a member of the Council on Foreign Relations.
Vice President and Directorwzyvaq@npprffu.bet
John-Michael Lind is a founding member of ACCESS Health International and a trustee of The Lind Family Trust. Mr. Lind is a serial entrepreneur and investor with over thirty nine private equity and venture investments to his credit, primarily in the US and in emerging markets. The most active investment sectors for Mr. Lind have been healthcare, life sciences, telecommunications, information technologies, information technology enabled services, energy, renewable energy, and infrastructure. His current interests and activities are focused on purposeful value investing, with a strong emphasis on positive social impact and sustainability, including affordable healthcare services and technologies, renewable energy, and affordable housing.
Mr. Lind has over twenty years of on the ground asset management and investment banking experience in India, South Asia, and Hong Kong, including as CEO and managing director of Ashmore India. Earlier, he founded and ran Strategic Partners, a US and India boutique advisory and investment firm managing proprietary capital, based in Mumbai and London. Prior to Strategic Partners, for two years, he was the initial CEO of Tata Telecom Maharashtra (formerly Hughes Ispat Ltd.), the basic telecom license holder for Maharashtra and Karnataka. Before moving to India, Mr. Lind was a senior associate at White & Case in London and New York. He began his career as a vice president at Salomon Brothers in New York and as an associate at O’Sullivan Graev & Karabell. Mr. Lind is on the board and investment committee of the Samena Capital India Credit Fund and is an advisor to numerous companies, including the Interlink Group, Essar, Cielo24, Cogi, and Aduro.
In addition to his work with ACCESS Health, Mr. Lind is an active supporter of numerous charitable endeavors, including the Santa Barbara Bowl Foundation, Storyteller, Room-to-Read, the Santa Barbara Museum of Natural History, and the Santa Barbara Museum of Modern Art. Mr. Lind has been a member of the Young President’s Organization (YPO) since 2009 and is a board member of its Doing Business with India Network. Mr. Lind has a Bachelor’s Degree in Economics and International Relations with distinction from Claremont McKenna College and a law degree from the University of California Hastings College of the Law, where he was a contributing editor on the International Comparative Law Review.
Tianqiao Chen is the founder, chairman, and chief executive officer of Shanda Group, a global investment group. Mr. Chen and his family founded Shanda Group in 1999, first as an online game company, with three subsidiaries listed on NASDAQ. The business has since expanded to include private equity, public market, and real estate investments.
Mr. Chen has been acknowledged internationally for his business acumen. Some of the awards and accolades he has received include recognition in China Central Television (CCTV) Economic Figures in 2003, receiving the Robert Mundell/World Executive Awards of Achievement in Business and Economy, being named to the MIT Technology Review TR100 in 2004, and being named to the BusinessWeek Asia Star Top 25 in 2005.
Mr. Chen holds a Bachelor’s degree in Economics from Fudan University. He also serves on several government boards within China and as a member of the board of directors at Fudan University. Mr. Chen and his wife and business partner, Chrissy Luo, have a personal passion for contributing to society and are actively involved in philanthropic work.
Molly Coye, MD, MPH, is the chief innovation officer of the University of California, Los Angeles (UCLA) Health System and the director of the UCLA Institute for Innovation in Health. She is an internationally recognized leader in advancing innovative approaches to healthcare delivery and an expert in the use of information and clinical technology to advance the health of communities. As chief innovation officer, Dr. Coye works to develop innovations that can transform the quality, value, and delivery of healthcare on a local, national, and global level. Prior to joining UCLA, she founded and led HealthTech, the premier technology forecasting organization in healthcare and chaired the advisory board for the Center for Technology and Aging at the Public Health Institute in Oakland, California. She also led a large medical group and independent practice association, directed product development at an early internet disease management company, and advised venture investors in health technology. Dr. Coye served as Commissioner of Health for the State of New Jersey, Director of the California Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene and Public Health. She currently serves as chair of the Board of Directors of the Program for Appropriate Technology in Health (PATH), one of the largest nonprofit organizations in international health, and is a current director of Aetna, Inc. Dr. Coye holds a Doctor of Medicine and a Master of Public Health from Johns Hopkins University.
Blaise Guerrand-Hermès is a managing partner in corporate buyouts, focusing on the financing and development of cross border companies and the restructuring of European brands and assets. Mr. Guerrand-Hermès was previously an associate and financial researcher at Ashmore Investment Management, the leading emerging markets asset manager, with stints in the UK and India, where one of his investment focus was the healthcare industry. Mr. Guerrand-Hermès started his career as an investment banker with NM Rothschild in London, focusing on equity issuances and capital markets. He is also deeply involved in his family business and has been a member of the Board of Directors of Hermès Sellier since 2009 and Hermès International since 2012. In addition to these duties, he sits on the boards of several international companies and has served as a Director on the Board of ACCESS Health International since its incorporation. Mr. Guerrand-Hermès holds a Bachelor of Science in Management and Master of Science in Entrepreneurship from HEC Paris.
Robert Hormats, PhD, is currently vice chairman of Kissinger Associates, Inc. He previously served as the Under Secretary of State for Economic Growth, Energy and the Environment from 2009 until 2013. Before his appointment at the State Department, Mr. Hormats was vice chairman of Goldman Sachs International, which he joined in 1982. He also served as Assistant Secretary of State for Economic and Business Affairs from 1981 to 1982, Ambassador and Deputy US Trade Representative from 1979 to 1981, and Senior Deputy Assistant Secretary for Economic and Business Affairs at the State Department from 1977 to 1979. He served as a senior staff member for International Economic Affairs on the National Security Council from 1969 to 1977, where he was senior economic advisor to Henry Kissinger. Mr. Hormats has been a visiting lecturer at Princeton University and served on the Board of Visitors of the Fletcher School of Law and Diplomacy and the Dean’s Council of the John F. Kennedy School of Government at Harvard University. He is also a member of the Council on Foreign Relations. Mr. Hormats earned a BA from Tufts University and an MA, MALD, and PhD from the Fletcher School of Law and Diplomacy at Tufts University.
K. Ranga Krishnan
Ranga Krishnan, MB, ChB, is the dean of Duke-NUS Graduate Medical School in Singapore and an international expert in treating brain disorders of the elderly. A native of Madras, India, Dr. Krishnan received his medical degree from Madras Medical College and came to Duke as a resident in 1981. After completing his psychology residency and neurobiology fellowship there, he was appointed to the faculty in 1985. He served as chair of the Department of Psychiatry from 1998 until 2009. As department chair, Dr. Krishnan created an innovative and extensive continuing medical education network that featured satellite delivery of content, live lectures, and archived web based material and was recognized as the leader in continuing psychiatric education. As dean of the new Duke-NUS Graduate Medical School, he built the education and research infrastructure. During his tenure, the school has developed and implemented a new method of learning called Team LEAD. Dr. Krishnan has written three books, more than fifty textbook chapters, and more than two hundred journal articles on the subjects of elderly depression, dementia, Alzheimer’s disease, panic disorder, bipolar disorder in late life, and obsessive compulsive disorder.
Lars Thunell, PhD, was the CEO and executive vice president of the International Finance Corporation, World Bank Group, the largest global development institution focused on the private sector. He brings over thirty years of management experience. Before leading the International Finance Corporation, he served as CEO of Skandinaviska Enskilda Banken, the leading corporate bank in Sweden. He was also CEO of Swedish insurer Trygg-Hansa and president and CEO of Securum, a bank model for financial crisis management. Mr. Thunell is also a non-executive director of Standard Chartered PLC and Kosmos Energy Limited, a senior advisor to the Blackstone Group and the Center for Strategic and International Studies, and chairman of African Risk Capacity Limited, a mutual weather index insurance company sponsored by the African Union. He received a PhD from the University of Stockholm and was a research fellow at the Harvard University Center for International Affairs.